Trials / Sponsors / Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc.
Industry · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulga Common Warts (Verruca Vulgaris), Common Warts, Human Papilloma Virus (HPV) | Phase 3 | 2026-03-01 |
| Recruiting | Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV) | Phase 3 | 2025-12-17 |
| Completed | Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma Basal Cell Carcinoma, Skin Cancer, Cancer of the Skin, Basal Cell | Phase 2 | 2022-02-01 |
| Completed | A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts Condylomata Acuminata, Papillomavirus Infections, Skin Diseases, Viral | Phase 2 | 2019-06-25 |
| Completed | Cantharidin and Occlusion in Verruca Epithelium Common Wart, Warts Hand, Warts | Phase 2 | 2018-03-27 |
| Completed | Cantharidin Application in Molluscum Patients-1 Molluscum Contagiosum | Phase 3 | 2018-03-21 |
| Completed | Cantharidin Application in Molluscum Patients Molluscum Contagiosum | Phase 3 | 2018-02-14 |
| Completed | Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum. Molluscum Contagiosum | Phase 2 | 2017-06-08 |